Nyxoah SA (NYXH)
NasdaqGM · USD · Healthcare · Medical Devices
$0.9082 (+6.05%) as of
Key statistics
- Market cap
- 92.49M
- Forward P/E
- -1.10
- EPS (TTM)
- -2.3300
- Dividend yield
- 0.00%
- 52-week range
- 0.8000 – 5.9200
- Beta
- 1.00
- Revenue (TTM)
- 21.66M
- Profit margin
- 0.00%
- Analyst target
- $3.70
- Volume
- 16.64k
About Nyxoah SA
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Mont-Saint-Guibert, Belgium
- Employees
- 153
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.